FAQ/Help |
Calendar |
Search |
Today's Posts |
01-31-2018, 02:55 PM | #1 | |||
|
||||
Grand Magnate
|
Ocrelizumab (marketed as Ocrevus) is now on the PBS list in Australia.
That means that it is now available for $A39.50 per script compared to $A$35,100 per year previously. Multiple sclerosis wonderdrug gets government subsidy Admins, I mistakenly posted this in the wrong forum - it belongs in the MS forum. Can you move it there please. Thanks.
__________________
Knowledge is power. Last edited by kiwi33; 02-01-2018 at 03:24 AM. Reason: Request to Admins. |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
I have NO Choice but to try Ocrevus | Multiple Sclerosis | |||
Second infusion with ocrevus | The Stumble Inn | |||
Ocrelizumab | Multiple Sclerosis | |||
Ocrelizumab? | Autoimmune Diseases |